Cleared Traditional

K993048 - ROCHE DIAGNOSTICS INFLUENZA A/B RAPID TEST (FDA 510(k) Clearance)

Dec 1999
Decision
101d
Days
Class 2
Risk

K993048 is an FDA 510(k) clearance for the ROCHE DIAGNOSTICS INFLUENZA A/B RAPID TEST. This device is classified as a Devices Detecting Influenza A, B, And C Virus Antigens (Class II - Special Controls, product code PSZ).

Submitted by Roche Diagnostics Corp. (Indianapolis, US). The FDA issued a Cleared decision on December 20, 1999, 101 days after receiving the submission on September 10, 1999.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3328. An Influenza Virus Antigen Detection Test System Is A Device Intended For The Qualitative Detection Of Influenza Viral Antigens Directly From Clinical Specimens In Patients With Signs And Symptoms Of Respiratory Infection..

Submission Details

510(k) Number K993048 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 10, 1999
Decision Date December 20, 1999
Days to Decision 101 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code PSZ — Devices Detecting Influenza A, B, And C Virus Antigens
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3328
Definition An Influenza Virus Antigen Detection Test System Is A Device Intended For The Qualitative Detection Of Influenza Viral Antigens Directly From Clinical Specimens In Patients With Signs And Symptoms Of Respiratory Infection.